Moat Biotechnology is a biopharmaceutical company in the clinical development stage.
Moat Biotechnology has raised $26K in total funding. The most recent round was Undisclosed. The last funding was announced in October 2025.
Moat Biotechnology's investors include Cortado Ventures, Boyd Street Ventures.
Moat Biotechnology is headquartered in Oklahoma City, United States.
Moat Biotechnology is a biopharmaceutical company in the clinical development stage.
Moat Biotechnology is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Moat Biotechnology — Funding & Investors." VCBacked, October 20, 2025, https://www.vcbacked.co/company/moat-biotechnology. Accessed September 30, 2026.
VCBacked. (2025). Moat Biotechnology — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/moat-biotechnology
{{cite web |title=Moat Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/moat-biotechnology |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated